← All trials
NCT04997590
N/AInterventional
Trials without FDA-defined phases, including trials of devices or behavioral interventions.
View on ClinicalTrials.gov ↗Timeline
- Start date
- Dec 10, 2020
- Primary completion
- Dec 10, 2021
- Completion date
- Dec 10, 2022
- First posted
- Aug 9, 2021
- Last posted
- Aug 9, 2021
- Enrollment
- 40
- Arms / groups
- 2 / —
- Source
- AACT · ingestion pipeline
Sponsors
- Shandong Province Qianfoshan HospitalLead sponsor
- Shandong Province Qianfoshan HospitalReponsible party - principal investigator
- Qilu Pharmaceutical Co., Ltd.Collaborator
- Shandong Province Qianfoshan HospitalOverall official - principal investigator
Drugs studied
Indications studied
CDEK-curated fields only — the ClinicalTrials.gov results mirror (baseline measures, adverse events, participant flow) is a separate, currently-dormant pipeline; see MIGRATION_PLAN.md.